Sentante today announced the completion of a first-of-its-kind remote stroke procedure in Scotland using its robotic platform. Specialist surgeons performed the procedures, guiding interventions from different hospitals in Florida and Dundee, Scotland. They performed...
Sentante today announced the completion of a first-of-its-kind remote stroke procedure in Scotland using its robotic platform. Specialist surgeons performed the procedures, guiding interventions...
Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...
Organon is selling its JADA post-partum haemorrhage (PPH) treatment system to Laborie Medical in a deal valued at up to $465m.
The US-based company will...
US-based Synchron has secured $200m in a Series D funding round to drive the commercial rollout of its Stentrode brain-computer interface (BCI) platform and...
Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...
Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform.
Ivy integrates advanced imaging, AI and robotic...
AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...
Penumbra announced positive results from its landmark STORM-PE randomised controlled trial.
The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system,...
Sentante today announced the completion of a first-of-its-kind remote stroke procedure in Scotland using its robotic platform. Specialist surgeons performed the procedures, guiding interventions...
Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...
Organon is selling its JADA post-partum haemorrhage (PPH) treatment system to Laborie Medical in a deal valued at up to $465m.
The US-based company will...
US-based Synchron has secured $200m in a Series D funding round to drive the commercial rollout of its Stentrode brain-computer interface (BCI) platform and...